Synpromics is a private company which has grown through ongoing investment from inside and outside the pharma and biotech industry. Initial investment was made by Friends and Family and Scottish Investment Bank, followed by investment from Calculus Capital.

Synpromics, a private company, has raised total funds of £3.7M from Friends & Family, Scottish Investment Bank, and, with the largest investment of £2.1M, Calculus Capital.

In addition, the company as been supported by numerous grant awards from Scottish Enterprise, InnovateUK and IBioIC, to the value of a further £0.75M of non-dilutive funding.

About Calculus Capital

Calculus Capital logoCalculus Capital is a specialist in creating and managing private equity funds for individuals. A pioneer in the Enterprise Investment Scheme (EIS) space, Calculus launched the UK’s first approved EIS fund in 1999 and has gone on to launch 15 further funds. Calculus seeks capital appreciation from dynamic, established, private UK companies across a multitude of sectors; Calculus prefers to invest £2M - £5M per company.

About Scottish Investment Bank

Scottish Investment Bank logoThe Scottish Investment Bank (SIB) is the investment arm of Scotland’s main economic development agency, Scottish Enterprise, operating Scotland-wide in partnership with Highlands and Islands Enterprise. It manages a suite of co-investment funds including the Scottish Co-investment Fund and the Scottish Venture Fund, which are partly funded by the European Regional Development Fund (ERDF). These investment funds support Scotland’s SME funding market to ensure businesses with growth and export potential have adequate access to growth capital.